europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Kaffe Bueno joins EuropaBio: unlocking coffee’s therapeutic and industrial potential

04/05/2021
PRESS RELEASE

Kaffe Bueno joins EuropaBio: unlocking coffee’s therapeutic and industrial potential

Brussels, 05 May 2021 – EuropaBio is pleased to announce that Kaffe Bueno has joined as a corporate member. The company was originally a runner up in the SME Award, winning a free period of EuropaBio Membership and in 2021 has converted that into Corporate Membership.

Established in 2016, Kaffe Bueno is a Danish company which employs green chemistry and biotechnology to upcycle coffee's post-consumption by-product into active and functional ingredients for cosmetics, nutraceuticals, and functional foods.

Kaffe Bueno’s vision is to transform the way people perceive coffee: “from looking at it as a tool to make it until the end of the day, to look at it as a magical bean with the potential of improving human health by using what lies inside it”.

EuropaBio Director-General Dr. Claire Skentelbery says “Kaffe Bueno represents how European industry can build economic and societal benefits and serve a circular economy at the same time. Coffee is everywhere and its potential is only partly fulfilled. We look forward to working with Kaffe Bueno to ensure that the company and its products have an impact across sectors.”

Kaffe Bueno’s Co-Founder and CEO, Juan Medina, added “Following the 2018 SME Award, where we were runner-up, we have been actively participating within the EuropaBio network and using varied resources to support our development. We look forward to our continued participation in EuropaBio, helping shape and improve the bioeconomy and biotechnology landscape from a growing SME perspective”.

Download the full PRESS RELEASE below.

Website Size (2)

Kaffe Bueno joins EuropaBio


Download
2021_05_G_PR_Kaffe-Bueno-joins-EuropaBioDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
16/03/2023

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies